Terms: = Pancreatic cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
912 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. The preliminary analysis of lymphatic flow around the connective tissues surrounding SMA and SpA elucidates patients' oncological condition in borderline-resectable pancreatic cancer.
Akita H; Asukai K; Mukai Y; Hasegawa S; Omori T; Miyata H; Ohue M; Sakon M; Wada H; Takahashi H
BMC Surg; 2024 Apr; 24(1):107. PubMed ID: 38614983
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With pancreatic cancer Treated With Perioperative Adjuvant Chemotherapy.
Kawahara S; Aoyama T; Murakawa M; Kanemoto R; Takahashi D; Kamioka Y; Hashimoto I; Maezawa Y; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Saito A; Morinaga S
Anticancer Res; 2024 Apr; 44(4):1711-1718. PubMed ID: 38537971
[TBL] [Abstract] [Full Text] [Related]
4. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
[TBL] [Abstract] [Full Text] [Related]
5. [Effectiveness of minimally invasive surgery in the treatment of pancreatic acinar cell carcinoma].
Tao M; Yuan CH; Ma CL; Jiang B; Li L; Wang HY; Xiu DR
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):950-955. PubMed ID: 38514344
[No Abstract] [Full Text] [Related]
6. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.
Timmer FEF; Geboers B; Ruarus AH; Vroomen LGPH; Schouten EAC; van der Lei S; Vos DJW; Dijkstra M; Schulz HH; Bakker J; van den Bemd BAT; van den Tol PM; Puijk RS; Lissenberg-Witte BI; de Gruijl TD; de Vries JJJ; Lagerwaard FJ; Scheffer HJ; Bruynzeel AME; Meijerink MR
Lancet Gastroenterol Hepatol; 2024 May; 9(5):448-459. PubMed ID: 38513683
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study.
Varzaru B; Iacob RA; Bunduc S; Manea I; Sorop A; Spiridon A; Chelaru R; Croitoru A; Topala M; Becheanu G; Dumbrava M; Dima S; Popescu I; Gheorghe C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474101
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
Huang JX; Zhang X; Tang M; Zhang Q; Deng L; Song CH; Li W; Shi HP; Cong MH
BMC Cancer; 2024 Mar; 24(1):293. PubMed ID: 38438901
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan.
Yamashita K; Oka S; Yamada T; Mitsui K; Yamamoto H; Takahashi K; Shiomi A; Hotta K; Takeuchi Y; Kuwai T; Ishida F; Kudo SE; Saito S; Ueno M; Sunami E; Yamano T; Itabashi M; Ohtsuka K; Kinugasa Y; Matsumoto T; Sugai T; Uraoka T; Kurahara K; Yamaguchi S; Kato T; Okajima M; Kashida H; Akagi Y; Ikematsu H; Ito M; Esaki M; Kawai M; Yao T; Hamada M; Horimatsu T; Koda K; Fukai Y; Komori K; Saitoh Y; Kanemitsu Y; Takamaru H; Yamada K; Nozawa H; Takayama T; Togashi K; Shinto E; Torisu T; Toyoshima A; Ohmiya N; Kato T; Otsuji E; Nagata S; Hashiguchi Y; Sugihara K; Ajioka Y; Tanaka S
J Gastroenterol; 2024 May; 59(5):376-388. PubMed ID: 38411920
[TBL] [Abstract] [Full Text] [Related]
10. Case report: From palliative to potentially curative - the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma.
Leong EKF; Tan NCH; Pang NQ; Kow AWC
Front Immunol; 2024; 15():1353430. PubMed ID: 38370411
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis.
Park JH; Shin JI; Lim BJ
Histopathology; 2024 Jun; 84(7):1079-1091. PubMed ID: 38362762
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.
Qiu X; Lu C; Sha H; Zhu Y; Kong W; Tong F; Wang Q; Meng F; Liu B; Du J
Front Immunol; 2024; 15():1210859. PubMed ID: 38361920
[TBL] [Abstract] [Full Text] [Related]
13. pancreatic Resection for pancreatic Tumors our Experience at Suburban Hospital.
Nichkaode PB; Sharma B; Reddy S; Inturi RT
Ann Afr Med; 2023; 22(4):537-543. PubMed ID: 38358158
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo pancreatic Adenocarcinoma.
Fogliati A; Zironda A; Fiorentini G; Adjei S; Amro A; Starlinger PP; Grotz TE; Warner SG; Smoot RL; Thiels CA; Kendrick ML; Cleary SP; Truty MJ
Ann Surg Oncol; 2024 Apr; 31(4):2632-2639. PubMed ID: 38319513
[TBL] [Abstract] [Full Text] [Related]
15. Textbook oncologic outcomes are associated with increased overall survival in patients with pancreatic head cancer after undergoing laparoscopic pancreaticoduodenectomy.
Zhang J; Cai H; Zhang M; Wang X; Cai Y; Peng B
World J Surg Oncol; 2024 Feb; 22(1):43. PubMed ID: 38317188
[TBL] [Abstract] [Full Text] [Related]
16. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
[TBL] [Abstract] [Full Text] [Related]
17. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
[TBL] [Abstract] [Full Text] [Related]
18. New Function Annotation of PROSER2 in pancreatic Ductal Adenocarcinoma.
Lee YS; Im J; Yang Y; Lee HJ; Lee MR; Woo SM; Park SJ; Kong SY; Kim JY; Hwang H; Kim YH
J Proteome Res; 2024 Mar; 23(3):905-915. PubMed ID: 38293943
[TBL] [Abstract] [Full Text] [Related]
19. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population.
Sini MC; Doro MG; Frogheri L; Zinellu A; Paliogiannis P; Porcu A; Scognamillo F; Delogu D; Santeufemia DA; Persico I; Palomba G; Maestrale GB; Cossu A; Palmieri G
J Transl Med; 2024 Jan; 22(1):108. PubMed ID: 38280995
[TBL] [Abstract] [Full Text] [Related]
20. [Survival of patients with pancreatic ductal adenocarcinoma].
Targarona J; Rivero L; Coayla G; Roman G; Rivas D; Legua S; Carrasco R
Rev Gastroenterol Peru; 2023; 43(4):300-308. PubMed ID: 38228295
[TBL] [Abstract] [Full Text] [Related]
[Next]
